Skip to content

iShares U.S. Medical Devices ETF

IHINYSE ArcaB

$52.69−0.10 (−0.19%)

At close: Oct 13, 2026, 4:00 PM

Intraday session: down, 79 prints from 52.79 to 52.69. Range 52.06 to 53.12. Use the arrow keys to read each point.52.0052.2052.4053.0010 AM12 PM2 PM4 PM
Expense ratio
0.37%
Fund size
$3.6B
1Y total return
−9.8%
Yield · Last 12 months
0.50%
Holdings
53
Avg volume · 30D
2.7M sh
NAV per share
$51.72
52W range
low $47.37high $64.71
Launched
Filings
SEC EDGAR

The ETF.net IHI Grade

Based on 5 of 6 pillars

B

Score 58 out of 100

Rank
10 of 25
Six-pillar profile for IHI. Scores out of 100: Cost 69, Risk 19, Mission not scored, Tradability 89, Holdings 29, Durability 86. Strongest: Tradability (89). Weakest: Risk (19). Based on 5 of 6 pillars.

Score 58 of 100 falls in the B band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    B69 out of 100
    Rank 7 of 25
  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    Not scored
  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    F19 out of 100
    Rank 21 of 24
  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    A89 out of 100
    Rank 2 of 25
  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    D29 out of 100
    Rank 22 of 25
  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    A86 out of 100
    Rank 3 of 25

Our read on IHI

ETF.net Research

BMedical devices only: pacemakers, insulin pumps, surgical robots. No pharma, no insurers, no hospitals riding along. iShares has run this narrow slice since 2006, and it costs less than the typical thematic fund.

Stated mandate

The fund seeks to track an index of U.S. equities focused on the medical devices sector, providing targeted exposure to domestic medical-equipment manufacturers and distributors.

Why people hold it

  1. 01At 0.37% a year, it undercuts the typical fund in its thematic peer group, which sits closer to 0.56%.
  2. 02Tracks the Dow Jones U.S. Select Medical Equipment Index: roughly 50 US device makers and distributors, and nothing else wearing a lab coat.ishares.com
  3. 03A multi-billion-dollar fund that trades actively, so entering and exiting rarely means wrestling with the spread.
  4. 04Live since 2006 and one of the sturdier builds in its thematic cohort, with no structural quirks flagged.

Worth knowing

  1. 01About 50 names means a handful of big device makers carry most of the weight. Single-company news lands harder here than in a broad healthcare fund.
  2. 02One narrow slice of one sector, all US-listed. It can travel a long way from the broad market in either direction.
  3. 03Distributions arrive quarterly, but the mandate is device-maker stock exposure, not a yield engine.

IHI Holdings

As of Oct 12, 2026
Asset class
Stocks
Holdings
53
Top-10 weight
76%
Largest holding
ABT17.7%

Sectors

  • Health Care100.0%

Geography

  • United States84.88%
  • Ireland14.31%
  • United Kingdom0.81%
The fund’s holdings, weight-ordered — page 1 of 4.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001ABTAbbott Laboratories17.70%6,356,339$633M376
002ISRGIntuitive Surgical15.38%1,297,722$550M410
003MDTMedtronic PLC11.63%4,702,080$416M320
004RMDResmed4.59%713,274$164M319
005BDXBecton Dickinson4.56%887,732$163M202
006SYKStryker4.49%579,594$161M350
007IDXXIdexx Laboratories4.49%309,840$160M355
008EWEdwards Lifesciences4.41%1,852,104$158M325
009DXCMDexcom Inc4.39%1,865,916$157M368
010BSXBoston Scientific Corp4.24%3,550,139$152M326
011GEHCGe Healthcare Technologies4.11%2,234,935$147M308
012STESteris2.89%482,433$103M267
013ZBHZimmer Biomet Holdings2.35%943,758$84M250
014BAXBaxter International1.74%2,558,097$62M190
015PENPenumbra1.74%194,898$62M127

Showing 1–15 of 53 holdings

IHI Performance

Launched May 1, 2006

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

IHI$9,017
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$12,044
Oct 10, 2025 to Oct 12, 2026. IHI $9,017. SPY $12,044. Use the arrow keys to read each point.$7,780$10,078$12,376Oct 2025Apr 2026Oct 2026

Oct 10, 2025 – Oct 12, 2026

Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for IHI. Periods over one year show the average yearly return.
PeriodIHI
Year to date−14.7%
1 month+3.9%
3 months+3.0%
1 year−9.8%
3 yearsper year+6.1%
5 yearsper year−2.7%
10 yearsper year+8.8%

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for IHI
YearReturn barIHI
2026 YTD−14.7%
2025+6.9%
2024+8.6%
2023+3.2%
2022−19.8%
2021+21.0%
2020+24.2%

IHI in the news

IHI Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 12, 2026.
0.50%Last 12 months
Payout per share
$0.26Last 12 months
Last payment
$0.08 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Quarterly

Distribution history

2017–2026

One bar per payment. 40 payments from 2017 to 2026 YTD. Mar 24, 2017 $0.02; Jun 27, 2017 $0.0089; Sep 26, 2017 $0.03; Dec 19, 2017 $0.05; Mar 22, 2018 $0.0032; Jun 26, 2018 $0.02; Sep 26, 2018 $0.02; Dec 17, 2018 $0.05; Jun 17, 2019 $0.04; Sep 24, 2019 $0.03; Dec 16, 2019 $0.07; Dec 30, 2019 $0.0062; Mar 25, 2020 $0.0035; Jun 15, 2020 $0.03; Sep 23, 2020 $0.03; Dec 14, 2020 $0.07; Mar 25, 2021 $0.0037; Jun 10, 2021 $0.05; Sep 24, 2021 $0.03; Dec 13, 2021 $0.07; Dec 30, 2021 $0.0061; Mar 24, 2022 $0.005; Jun 9, 2022 $0.05; Sep 26, 2022 $0.11; Dec 13, 2022 $0.07; Mar 23, 2023 $0.02; Jun 7, 2023 $0.05; Sep 26, 2023 $0.12; Dec 20, 2023 $0.10; Mar 21, 2024 $0.03; Jun 11, 2024 $0.05; Sep 25, 2024 $0.08; Dec 17, 2024 $0.11; Mar 18, 2025 $0.03; Jun 16, 2025 $0.06; Sep 16, 2025 $0.06; Dec 16, 2025 $0.06; Mar 17, 2026 $0.04; Jun 15, 2026 $0.08; Sep 15, 2026 $0.08. Use the arrow keys to read each point.2017201820192020202120222023202420252026YTD
Ex-datePay dateAmount per share
Sep 15, 2026Sep 18, 2026$0.08
Jun 15, 2026Jun 18, 2026$0.08
Mar 17, 2026Mar 20, 2026$0.04
Dec 16, 2025Dec 19, 2025$0.06
Sep 16, 2025Sep 19, 2025$0.06
Jun 16, 2025Jun 20, 2025$0.06
Mar 18, 2025Mar 21, 2025$0.03
Dec 17, 2024Dec 20, 2024$0.11
Sep 25, 2024Sep 30, 2024$0.08
Jun 11, 2024Jun 17, 2024$0.05
Mar 21, 2024Mar 27, 2024$0.03
Dec 20, 2023Dec 27, 2023$0.10

IHI Risk

How much the fund’s monthly returns vary, scaled to a year.
17.7%
Annualised · 36 months to Sep 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
−0.04
vs 3-month T-bills · to Sep 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−32.4%
Trough Oct 2023
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.82
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

IHI Cost

Expense ratio0.37%
  • The middle half of Health Care (Broad) funds
  • Median 0.50%

6 of the 25 Health Care (Broad) funds charge less.

IHI costs $37.00 a year on $10,000. The median Health Care (Broad) fund costs $50.00.

Other funds in Health Care (Broad)